Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2012 - 2026)

Enanta Pharmaceuticals (ENTA) has 15 years of Amortizatization of Intangibles data on file, last reported at -$302000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 62.99% year-over-year to -$302000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $623000.0 (up 5763.64% YoY) and the FY2025 annual result came in at -$503000.0, down 144.2% from the prior year.
• Amortizatization of Intangibles retreated to -$302000.0 in Q1 2026, from -$20000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.4 million in Q2 2023 to a low of -$816000.0 in Q1 2025.
• A 5-year average of $149647.1 and a median of -$20000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 1778.12% — and 2025, when it plunged 3164.0%.
• Tracing ENTA's Amortizatization of Intangibles over 5 years: stood at $339000.0 in 2022, then sank by 180.83% to -$274000.0 in 2023, then sank by 130.66% to -$632000.0 in 2024, then surged by 96.84% to -$20000.0 in 2025, then slumped by 1410.0% to -$302000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at -$302000.0 (Q1 2026), -$20000.0 (Q4 2025), and $958000.0 (Q3 2025), per Business Quant data.